The purpose of this study is to investigate if receiving doses of arginine (a protein in the
body) will improve mitochondria function in children with COVID-19.
The study will be performed in Children's Healthcare of Atlanta, Egleston campus. Patients
will be randomized to receive one of three doses of arginine three times a day for five days
or at discharge whichever comes first.